Lasting response by vertical inhibition with cetuximab and trametinib in KRAS-mutated colorectal cancer patient-derived xenografts

Reissig, Timm M.; Ladigan-Badura, Swetlana; Steinberg, Anja; Maghnouj, Abdelouahid; Li, Ting; Verdoodt, Berlinda; Liffers, Sven T.; Pohl, Michael; Wolters, Heiner; Teschendorf, Christian; Viebahn, Richard; Admard, Jakob; Casadei, Nicolas; Tannapfel, Andrea; Schmiegel, Wolff; Hahn, Stephan A.; Vangala, Deepak B.

dc.contributor.author	Admard, Jakob
dc.contributor.author	Casadei, Nicolas
dc.date.accessioned	2024-05-28T05:39:17Z
dc.date.available	2024-05-28T05:39:17Z
dc.date.issued	2023
dc.identifier.issn	1574-7891
dc.identifier.uri	http://hdl.handle.net/10900/153731
dc.language.iso	en	de_DE
dc.publisher	Hoboken : Wiley	de_DE
dc.relation.uri	http://dx.doi.org/10.1002/1878-0261.13510	de_DE
dc.subject.ddc	610	de_DE
dc.title	Lasting response by vertical inhibition with cetuximab and trametinib in KRAS-mutated colorectal cancer patient-derived xenografts	de_DE
dc.type	Article	de_DE
utue.quellen.id	20240124000000_01293
utue.publikation.seiten	2396-2414	de_DE
utue.personen.roh	Reissig, Timm M.
utue.personen.roh	Ladigan-Badura, Swetlana
utue.personen.roh	Steinberg, Anja
utue.personen.roh	Maghnouj, Abdelouahid
utue.personen.roh	Li, Ting
utue.personen.roh	Verdoodt, Berlinda
utue.personen.roh	Liffers, Sven T.
utue.personen.roh	Pohl, Michael
utue.personen.roh	Wolters, Heiner
utue.personen.roh	Teschendorf, Christian
utue.personen.roh	Viebahn, Richard
utue.personen.roh	Admard, Jakob
utue.personen.roh	Casadei, Nicolas
utue.personen.roh	Tannapfel, Andrea
utue.personen.roh	Schmiegel, Wolff
utue.personen.roh	Hahn, Stephan A.
utue.personen.roh	Vangala, Deepak B.
dcterms.isPartOf.ZSTitelID	Molecular Oncology	de_DE
dcterms.isPartOf.ZS-Issue	11	de_DE
dcterms.isPartOf.ZS-Volume	17	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE